Alok Kumar, a postdoc at the University of Pittsburgh, examines how immediate dietary inputs and nutrient status reprogram T cell metabolic capacity to improve cellular therapies.

Bruno and colleagues provide an overview of tertiary lymphoid structures as biomarkers and potential therapeutic targets in the cancer immunotherapy era.

University of Pittsburgh postdoctoral researcher Mary Cundiff uses machine learning and single-cell genomics to study systemic diseases across organs.

April 27, 2026University of Pittsburgh Department of Immunology faculty and students are advancing understanding of fundamental immune mechanisms and developing new approaches for diagnosing and treat...

Dr. Greg Delgoffe explores how the tumor microenvironment functions as a complex, dynamic ecosystem that shapes the success or failure of cancer immunotherapy.